Hypertension and Bone Health Interactions

Hypertension and bone health are entwined through shared biological pathways that involve vascular function, hormonal regulation and mechanical loading. Elevated arterial pressure can alter the microcirculation of bone, impairing nutrient delivery and promoting low-grade inflammation. The local renin–angiotensin system within bone tissue influences the balance between osteoclast-mediated resorption and osteoblast-mediated formation. Chronic blood pressure elevation is associated with reduced bone mineral density, compromised microarchitecture and increased fracture risk. Conversely, bone-derived factors such as osteocalcin may modulate systemic vascular tone. Understanding this bidirectional relationship has broad implications for the prevention of osteoporotic fractures in hypertensive populations and for optimising antihypertensive therapy to preserve bone integrity.

Research from Nature Portfolio

A seminal study using spontaneously hypertensive rats comprehensively characterised bone deficits arising from long-term blood pressure elevation. High-resolution tomography revealed marked trabecular porosity, reduced cortical thickness and lower volumetric bone mineral density in affected animals. Mechanical testing demonstrated diminished yield load and stiffness, indicating increased susceptibility to fracture. At the cellular level, primary osteoblast cultures from hypertensive rats showed downregulated markers of bone formation, whereas osteoclastogenic markers were upregulated, signifying an imbalance in remodelling. These findings establish a direct causal link between systemic hypertension and defective bone mass and strength, underscoring the need for integrated therapeutic strategies that concurrently target blood pressure control and bone preservation.

Hypertension and Bone Health Interactions publication trend

The graph below shows the total number of articles in hypertension and bone health interactions across all publications each year (not limited to Nature Index journals).

Technical terms

Renin–angiotensin–aldosterone system (RAAS): A hormonal cascade regulating blood pressure and fluid balance, with local bone effects on cell differentiation.

Osteoclastogenesis: The process by which precursor cells differentiate into osteoclasts, specialised cells that resorb bone matrix.

Bone mineral density (BMD): A quantitative measure of mineral content in bone tissue, used as an indicator of strength and fracture risk.

Osseointegration: The direct structural and functional connection between living bone and the surface of a load-bearing implant.

References

1. Estrogen Deficiency Impairs Osseointegration in Hypertensive Rats Even Treated with Alendronate Coated on the Implant Surface. Journal of Functional Biomaterials (2023).
2. Azilsartan inhibits inflammation-triggered bone resorption and osteoclastogenesis in vivo via suppression of TNF-α expression in macrophages. Frontiers in Endocrinology (2023).
3. The Relationship between Renin–Angiotensin–Aldosterone System (RAAS) Activity, Osteoporosis and Estrogen Deficiency in Type 2 Diabetes. International Journal of Molecular Sciences (2023).
4. Impairment of bone microstructure and upregulation of osteoclastogenic markers in spontaneously hypertensive rats. Scientific Reports (2019).